Sign in
4

Changes in Ownership

Neurogene Inc. Filed Acc 0001209191-15-026541

Options or other derivatives

  • President and CEO acquired 65,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Main David · President and CEO

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2015-03-12 Grant or award : show line 1 in the form Stock Option (Right to Buy) +65,000 $12.03 2025-03-11 65,000 65,000 D
Loading xslF345X03/doc4.xml…